Fast, flexible material for early-stage development

Synecta™ T1 Research Grade is designed for discovery, proof-of-concept studies, assay development, and early process development where speed, flexibility, and consistent performance are essential.

Research Grade gives cell therapy developers access to the same Synecta T1 activation technology they can carry forward as their manufacturing process advances. Each lot is produced using a defined manufacturing process, undergoes BlueWhale Bio technical review, quality control testing and release, and is supplied with a lot-specific Certificate of Analysis.

Synecta T1 Research Grade is well suited for:

• Discovery and proof-of-concept studies
• Assay development
• Activation and expansion optimization
• Process development
• Platform and workflow evaluation
• Early scale-up studies